named programs · 2 · from sources
What they call their work
Commercial Innovation Network
A curated community of senior experts in life sciences and healthcare innovation that mentors clients and provides rapid access to specialized expertise for advancing health technologies.
Digitalis Commons Partnership Program
Provides direct support to public and philanthropic funders to transition early-stage health technologies from concept to patients, offering business consulting, investment strategy, and technology development services.
activities · 4 groups
What they do
-
Biomedical Research and Innovation 2 activities
- Coordination of multi-sector consortia for public-interest technology developmentCoordinates consortia of academic, nonprofit, and industry partners to advance biomedical technology development while embedding public interest conditions. Convenes coalitions of public and private leaders and leads precompetitive collaborations to promote safe, effective, and equitable digital medicine.
- Development of biomedical technologies for public interest and neglected diseasesDevelops biomedical technologies to address complex health problems, particularly for underserved populations and neglected diseases, ensuring scientific knowledge is treated as a shared commons and publicly funded research translates into accessible solutions. Works in collaboration with academic institutions, nonprofits, and industry partners.
-
-
Oral History Collection and Preservation 1 activity
- Feasibility research through oral history collectionCollected preliminary oral history data from 10 interviews to demonstrate the feasibility of the Magnolia Project.
-
-
Medical Research Funding 1 activity
- Management of technology translation from concept to patientProvides direct support to public and philanthropic funders to advance early-stage health technologies through the translational pipeline, including scientific development, regulatory strategy, manufacturing partnerships, and clinical evidence generation. Manages a partnership with ARPA-H involving $2.5 billion in federal funding for transformative health breakthroughs.
-
-
Uncategorized 2 activities
- Client and partner relationship managementManages client and partner relationships for Digitalis Commons to support organizational operations and collaborative initiatives.
- Development and deployment of digital health platformsCreated CoronaBR, a virtual triage platform that received over 1 million visits in its first 24 hours and reached more than 20 million people globally. Also founded Kintsu, which developed Bioplanner to improve access to care for patients with rare and immune-mediated diseases.
-
financials · form 990 · fy2024
revenue
Total revenue$4.76M
Contributions & grants$4.68M98%
Program service revenue$00%
Investment income$75K2%
Other revenue$0
expenses
Total expenses$3.93M
Program expenses91%
Admin / overhead8%
Fundraising1%
Salaries & benefits$1.93M
Grants paid out$0
Largest expense lineCompensation
balance sheet
Total assets$4.40M
Cash$4.37M
Investments$5K
Liabilities$1.89M
Net assets$2.50M
Liquid reserves13.4 mo
4 years on record · 2020–2024 · YoY revenue +126.5%
leadership · form 990 part vii · fy2024
Who runs it
paid leadership · 5
| Name | Title | Hours/wk | Compensation |
|---|---|---|---|
| LARA MANGRAVITE | EXECUTIVE DIRECTOR | 40 | $389K |
| JANICE LOUIE | DIRECTOR OF COMMERCIALIZATION TEAM | 40 | $289K |
| IDIN JAFARI | COMMERCIALIZATION LEAD | 40 | $228K |
| RUT PENA | COMMERCIALIZATION LEAD | 40 | $212K |
| GEOFFREY SMITH | CHARIMAN/TREASURER | 10 | $150K |
board members · 3
- BRIAN TRELSTAD — BOARD MEMBER
- JENNIFER FRIEL GOLDSTEIN — BOARD MEMBER
- MISTI USHIO — BOARD MEMBER
relationships · 14
Who they work with
- Advanced Research Projects Agency for Health Government — Foundational public-private partner that provides research funding to support transformative biomedical and health breakthroughs; Digitalis Commons supports ARPA-H in transitioning early-stage health technologies to patients.
- Brazil’s Ministry of Health Government — Recommended the CoronaBR virtual triage platform.
- Brigham & Women’s Hospital Partner — Geoffrey W. Smith is a founding member of the Scientific Advisory Board.
- Digital Medicine Society Partner — Former organization where Sarah Valentine convened coalitions and led collaborations in digital medicine.
- Eli Lilly Partner — Former employer where Sarah Valentine served as Digital Implementation Lead.
- IBM Partner — Supported the CoronaBR virtual triage platform.
- Icahn School of Medicine at Mount Sinai Partner — Geoffrey W. Smith was a founding Director of the Mount Sinai Institute of Technology and Professor in the Department of Population Health Science and Policy.
- Partnership Fund for New York City Partner — Geoffrey W. Smith serves as a Director.
- Salzburg Global Partner — Geoffrey W. Smith serves as a Director.
- The Jackson Laboratory Government — Geoffrey W. Smith serves as a Trustee and Chair of the Finance & Investment Committee.
- Wellcome Trust Partner — Advised by Aline Okita in advancing mental health technologies from innovation to real-world impact.
- academic partners Partner — Collaborates with academic institutions as part of consortia to advance technology development.
- industry partners Partner — Collaborates with industry entities as part of consortia to advance technology development.
- nonprofit partners Partner — Collaborates with nonprofit organizations as part of consortia to advance technology development.
strategies · 5
How they approach the work
Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.
- Equitable Access Through Commons-Based Stewardshipmethodology: knowledge commonsBy treating foundational scientific knowledge as a shared commons and embedding access and affordability into technology design, we ensure public benefit from publicly funded research, because equitable access is a core condition of just innovation.
- Hybrid Financing to Sustain Mission Integritymethodology: hybrid_financing_modelBy combining philanthropic, public, and earned income streams, we sustain technology development while protecting mission integrity, because reliance on any single funding source risks misalignment with public-interest goals.
- Market-Failure Targeting for Biomedical Innovationmethodology: market-failure targetingBy focusing on biomedical opportunities where scientific promise and unmet medical need intersect with market failure, we achieve impact in areas neglected by conventional industry models, because profit-driven innovation leaves critical health gaps unaddressed.
- Precompetitive Collaboration for Equity in Digital Medicinemethodology: precompetitive_collaborationBy leading collaborations among public and private entities before competitive stages, we promote safety, effectiveness, and equity in digital medicine, because shared standards and open development prevent exclusionary practices from emerging early in innovation cycles.
- Public Interest Technology Developmentmethodology: public_interest_technologyBy developing open, accessible, and ethically designed digital tools through nonprofit-led research and applied development, we solve complex health problems and ensure technologies serve broad public benefit rather than market-driven incentives, because technology shaped by mission rather than profit can address systemic inequities in health care.